drugset / Trial / NCT01328821
Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of CTP-499 following single dose administration.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-04
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CTP-499 | Small molecule | 400 mg | — |
| Comparator | CTP-499 | Small molecule | 600 mg | — |
| Comparator | CTP-499 | Small molecule | 1200 mg | — |
| Comparator | CTP-499 | Small molecule | 1800 mg | — |
| Comparator | CTP-499 | Small molecule | 2400 mg | — |